Mark Holliday

2.6k total citations · 1 hit paper
32 papers, 1.0k citations indexed

About

Mark Holliday is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mark Holliday has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 19 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Mark Holliday's work include Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (17 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Mark Holliday is often cited by papers focused on Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (17 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Mark Holliday collaborates with scholars based in New Zealand, United Kingdom and Australia. Mark Holliday's co-authors include T Leese, Richard Beasley, Mark Weatherall, Irene Braithwaite, J. Cohen, R A Swann, Andrew Exley, Helen K. Reddel, Robert J. Hancox and Ian Pavord and has published in prestigious journals such as New England Journal of Medicine, Gut and European Respiratory Journal.

In The Last Decade

Mark Holliday

31 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

2019 266 citations Richard Beasley, Mark Holliday et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Holliday New Zealand	14	487	448	334	192	132	32	1.0k
Diego J. Maselli United States	20	797 1.6×	388 0.9×	121 0.4×	27 0.1×	276 2.1×	70	1.2k
Bernie Higgins United Kingdom	16	189 0.4×	293 0.7×	305 0.9×	142 0.7×	247 1.9×	18	1.2k
Concepción Montón Spain	20	755 1.6×	210 0.5×	88 0.3×	32 0.2×	383 2.9×	45	1.2k
Paola Faverio Italy	20	935 1.9×	268 0.6×	84 0.3×	53 0.3×	475 3.6×	75	1.6k
Süleyman Savaş Hacıevliyagil Türkiye	15	575 1.2×	202 0.5×	68 0.2×	32 0.2×	105 0.8×	34	836
Jefferson Antonio Buendía Colombia	13	265 0.5×	157 0.4×	117 0.4×	52 0.3×	196 1.5×	103	720
Theodore W. Marcy United States	20	862 1.8×	250 0.6×	84 0.3×	28 0.1×	128 1.0×	31	1.2k
Katalin Márta Hungary	19	149 0.3×	109 0.2×	441 1.3×	184 1.0×	180 1.4×	41	841
J. Ostinelli France	16	954 2.0×	642 1.4×	41 0.1×	27 0.1×	248 1.9×	29	1.3k
Dennis E. Amundson United States	14	176 0.4×	128 0.3×	275 0.8×	38 0.2×	225 1.7×	34	907

Countries citing papers authored by Mark Holliday

Since Specialization

Citations

This map shows the geographic impact of Mark Holliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holliday more than expected).

Fields of papers citing papers by Mark Holliday

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Holliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holliday. The network helps show where Mark Holliday may publish in the future.

Co-authorship network of co-authors of Mark Holliday

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Holliday. A scholar is included among the top collaborators of Mark Holliday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Holliday. Mark Holliday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noble, J, Pepa Bruce, R. R. Sayers, et al.. (2025). Protocol for the INFORM ASTHMA Trial: budesonide–formoterol reliever in adults with asthma on maintenance inhaled corticosteroid. ERJ Open Research. 11(4). 1208–2024.

Hatter, Lee, Mark Holliday, Allie Eathorne, et al.. (2024). The carbon footprint of as-needed budesonide/formoterol in mild asthma: apost hocanalysis. European Respiratory Journal. 64(1). 2301705–2301705. 10 indexed citations

Bruce, Pepa, Lee Hatter, Claire Houghton, et al.. (2023). The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthma. ERJ Open Research. 9(5). 239–2023. 1 indexed citations

Foster, Juliet M., Richard Beasley, Irene Braithwaite, et al.. (2022). Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study. BMJ Open. 12(1). e048537–e048537. 9 indexed citations

Kearns, Nethmi, Ciléin Kearns, Allie Eathorne, et al.. (2021). How big is your bubble? Characteristics of self-isolating household units (‘bubbles’) during the COVID-19 Alert Level 4 period in New Zealand: a cross-sectional survey. BMJ Open. 11(1). e042464–e042464. 20 indexed citations

Baggott, Christina, Paul Hansen, Robert J. Hancox, et al.. (2020). What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment. Thorax. 75(10). 842–848. 14 indexed citations

Hatter, Lee, Pepa Bruce, Irene Braithwaite, et al.. (2020). ICS-formoterol relieverversusICS and short-acting β₂-agonist reliever in asthma: a systematic review and meta-analysis. ERJ Open Research. 7(1). 701–2020. 45 indexed citations

Baggott, Christina, Jo Hardy, Jenny Sparks, et al.. (2020). Self-titration of inhaled corticosteroid and β₂-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial. European Respiratory Journal. 56(4). 2000170–2000170. 7 indexed citations

Baggott, Christina, Helen K. Reddel, Jo Hardy, et al.. (2020). Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial. European Respiratory Journal. 55(4). 1902073–1902073. 26 indexed citations

10.

Foster, Juliet M., Richard Beasley, Irene Braithwaite, et al.. (2020). Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study. Respiratory Medicine. 175. 106154–106154. 16 indexed citations

11.

Hardy, Jo, Jordan Tewhaiti-Smith, Christina Baggott, et al.. (2020). Combination budesonide/formoterol inhaler as sole reliever therapy in Māori and Pacific people with mild and moderate asthma.. PubMed. 133(1520). 61–72. 5 indexed citations

12.

Beasley, Richard, Mark Holliday, Helen K. Reddel, et al.. (2019). Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma. New England Journal of Medicine. 380(21). 2020–2030. 266 indexed citations breakdown →

13.

Beasley, Richard, Mark Holliday, Helen K. Reddel, et al.. (2019). Pragmatic Randomized Controlled Trial of Budesonide/Formoterol Reliever Therapy in Adults with Mild Asthma. A7477–A7477. 1 indexed citations

14.

Fingleton, James, Jo Hardy, Christina Baggott, et al.. (2017). Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma. BMJ Open Respiratory Research. 4(1). e000217–e000217. 13 indexed citations

15.

Power, Sharon, Mathew Williams, Alex Semprini, et al.. (2017). RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study. BMJ Open. 7(3). e013850–e013850. 5 indexed citations

16.

Holweg, Cécile, John G. Matthews, Mark Holliday, et al.. (2017). Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma. Allergy Asthma and Clinical Immunology. 13(1). 8–8. 10 indexed citations

17.

Braithwaite, Irene, Anna Hunt, James Fingleton, et al.. (2015). Randomised controlled trial of topical kanuka honey for the treatment of rosacea. BMJ Open. 5(6). e007651–e007651. 27 indexed citations

18.

Young, Paul J., Manoj Saxena, Rinaldo Bellomo, et al.. (2015). Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. New England Journal of Medicine. 373(23). 2215–2224. 132 indexed citations

19.

Exley, Andrew, T Leese, Mark Holliday, R A Swann, & J. Cohen. (1992). Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.. Gut. 33(8). 1126–1128. 181 indexed citations

20.

Holliday, Mark, David E. Shaw, W. M. Thomas, & T Leese. (1989). Threshold for albumin as a prognostic marker in acute pancreatitis. British journal of surgery. 76(5). 472–473. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact